A House committee in Washington State has amended and approved a psilocybin bill—inserting some therapeutic access provisions back into the legislation after the Senate had stripped it down to focus on research only
The amendment, from Rep. Nicole Macri (D), was approved on a voice vote Wednesday by the House Health Care and Wellness Committee. The panel went on to approve the amended bill on a bipartisan 13–4 vote. Three of the panel’s seven Republican members, as well as all ten Democrats, ultimately supported the psilocybin measure.
